share_log

Prestige Consumer Healthcare (NYSE:PBH) Sets New 12-Month Low at $49.81

Prestige Consumer Healthcare (NYSE:PBH) Sets New 12-Month Low at $49.81

威望消費者醫療保健公司(紐約證券交易所代碼：PBH)將12個月新低定為49.81美元
Defense World ·  2022/09/24 04:51

Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating)'s share price reached a new 52-week low on Thursday . The company traded as low as $49.81 and last traded at $49.81, with a volume of 18 shares traded. The stock had previously closed at $50.55.

週四，威望消費者醫療保健公司(NYSE：PBH-GET Rating)的股價創下52周來的新低。該公司股價一度跌至49.81美元，最新報49.81美元，成交量為18股。此前該股收盤價為50.55美元。

Analyst Ratings Changes

分析師評級發生變化

Separately, DA Davidson reaffirmed a "neutral" rating on shares of Prestige Consumer Healthcare in a research report on Tuesday, August 9th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $80.50.

另外，DA Davidson在8月9日星期二的一份研究報告中重申了對Prestige Consumer Healthcare股票的“中性”評級。兩名投資分析師對該股的評級為持有，三名分析師對該公司的評級為買入。根據MarketBeat.com的數據，該公司目前的共識評級為“適度買入”，共識目標價為80.50美元。

Get
到達
Prestige Consumer Healthcare
威望消費者醫療保健
alerts:
警報：

Prestige Consumer Healthcare Stock Down 0.8 %

威望消費者醫療保健類股下跌0.8%

The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.23 and a current ratio of 2.09. The firm has a fifty day moving average price of $55.14 and a 200 day moving average price of $55.41. The firm has a market capitalization of $2.50 billion, a price-to-earnings ratio of 12.61, a PEG ratio of 1.50 and a beta of 0.55.

該公司的債務權益比率為0.93，速動比率為1.23，流動比率為2.09。該公司的50日移動平均價為55.14美元，200日移動平均價為55.41美元。該公司的市值為25億美元，市盈率為12.61倍，聚乙二醇率為1.50倍，貝塔係數為0.55。

Institutional Trading of Prestige Consumer Healthcare

威望消費者醫療保健的機構交易

Several hedge funds have recently modified their holdings of PBH. BlackRock Inc. increased its stake in Prestige Consumer Healthcare by 12.4% in the 1st quarter. BlackRock Inc. now owns 9,115,718 shares of the company's stock valued at $482,584,000 after purchasing an additional 1,004,337 shares in the last quarter. Vanguard Group Inc. increased its stake in Prestige Consumer Healthcare by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 5,559,553 shares of the company's stock valued at $294,322,000 after purchasing an additional 59,740 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Prestige Consumer Healthcare by 0.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,448,246 shares of the company's stock valued at $182,552,000 after purchasing an additional 12,790 shares in the last quarter. State Street Corp increased its stake in Prestige Consumer Healthcare by 4.9% in the 2nd quarter. State Street Corp now owns 1,921,456 shares of the company's stock valued at $112,982,000 after purchasing an additional 89,131 shares in the last quarter. Finally, Macquarie Group Ltd. increased its stake in Prestige Consumer Healthcare by 4.4% in the 2nd quarter. Macquarie Group Ltd. now owns 1,887,479 shares of the company's stock valued at $110,984,000 after purchasing an additional 79,519 shares in the last quarter. 99.37% of the stock is owned by institutional investors and hedge funds.
幾家對衝基金最近調整了對PBH的持股。貝萊德股份有限公司在第一季度增持了Prestige Consumer Healthcare 12.4%的股份。貝萊德股份有限公司在上個季度增持了1,004,337股後，目前持有該公司9,115,718股股票，價值482,584,000美元。先鋒集團第一季度增持Prestige Consumer Healthcare股份1.1%。先鋒集團目前持有該公司5,559,553股股票，價值294,322,000美元，上一季度又購買了59,740股。Dimension Fund Advisors LP在第一季度增持Prestige Consumer Healthcare的股份0.4%。Dimension Fund Advisors LP現在擁有該公司3,448,246股股票，價值182,552,000美元，上個季度又購買了12,790股。道富集團第二季度增持Prestige Consumer Healthcare股份4.9%。道富銀行目前持有1,921,456股該公司股票，價值112,982,000美元，上一季度又購買了89,131股。最後，麥格理集團有限公司在第二季度將其在Prestige Consumer Healthcare的持股增加了4.4%。麥格理集團目前持有該公司1,887,479股股票，價值110,984,000美元，上一季度又購買了79,519股。99.37%的股票由機構投資者和對衝基金持有。

About Prestige Consumer Healthcare

關於Prestige Consumer Healthcare

(Get Rating)

(獲取評級)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

威望消費者保健公司及其子公司在美國和國際上開發、製造、營銷、分銷和銷售非處方藥(OTC)健康和個人護理產品。該公司在北美OTC Healthcare和國際OTC Healthcare兩個部門運營。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • Will Crowdstrike Get A Boost From Increased EPS Guidance?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • 免費獲取StockNews.com關於Prestige Consumer Healthcare(PBH)的研究報告
  • MarketBeat：回顧一週9/19-9/23
  • 為什麼特斯拉的股票保持彈性？
  • 好市多盈利後價格疲軟是買入的好時機嗎？
  • CrowdStrike是否會從增加每股收益指引中獲得提振？
  • 小盤股的裁員是樓市的晴雨表嗎？

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

獲得《尊貴消費者保健日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Prestige Consumer Healthcare和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論